MA50363A - Vaccin contre la parodontite et compositions associées et procédé d'utilisation - Google Patents
Vaccin contre la parodontite et compositions associées et procédé d'utilisationInfo
- Publication number
- MA50363A MA50363A MA050363A MA50363A MA50363A MA 50363 A MA50363 A MA 50363A MA 050363 A MA050363 A MA 050363A MA 50363 A MA50363 A MA 50363A MA 50363 A MA50363 A MA 50363A
- Authority
- MA
- Morocco
- Prior art keywords
- related compositions
- periodontitis
- vaccine
- periodontitis vaccine
- compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 201000001245 periodontitis Diseases 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0216—Bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762571582P | 2017-10-12 | 2017-10-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA50363A true MA50363A (fr) | 2020-08-19 |
Family
ID=64110091
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA050363A MA50363A (fr) | 2017-10-12 | 2018-10-11 | Vaccin contre la parodontite et compositions associées et procédé d'utilisation |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US10835590B2 (enExample) |
| EP (1) | EP3694547A1 (enExample) |
| JP (2) | JP7258870B2 (enExample) |
| KR (2) | KR102530966B1 (enExample) |
| CN (1) | CN111225684A (enExample) |
| AU (1) | AU2018347511A1 (enExample) |
| CA (1) | CA3078630A1 (enExample) |
| EA (1) | EA202090908A1 (enExample) |
| IL (1) | IL273690A (enExample) |
| MA (1) | MA50363A (enExample) |
| MX (1) | MX2020003810A (enExample) |
| PH (1) | PH12020550239A1 (enExample) |
| SG (1) | SG11202003147XA (enExample) |
| WO (1) | WO2019075260A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111225684A (zh) | 2017-10-12 | 2020-06-02 | Sutrovax公司 | 牙周炎疫苗和相关组合物及使用方法 |
| US12637503B2 (en) | 2020-11-03 | 2026-05-26 | K-Bio Investment, Llc | Antigen-binding molecules that bind to Porphyromonas gingivalis |
| WO2025019900A1 (en) * | 2023-07-26 | 2025-01-30 | Denteric Pty Ltd | Chimeric protein vaccine |
| CN116751292B (zh) * | 2023-07-31 | 2024-05-14 | 河南大学 | 牙龈卟啉单胞菌Mfa1单克隆抗体及其应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59128338A (ja) | 1982-12-08 | 1984-07-24 | Kitasato Inst:The | 歯周炎予防用ワクチン及びその製法 |
| WO1994028014A2 (en) | 1993-05-28 | 1994-12-08 | Chiron Corporation | Peptide inhibitors of urokinase receptor activity |
| AUPN627595A0 (en) * | 1995-10-30 | 1995-11-23 | University Of Melbourne, The | Diagnostics and treatments of periodontal disease |
| JP2000507245A (ja) | 1996-03-22 | 2000-06-13 | ユニバーシティー オブ ジョージア リサーチ ファウンデーション，インコーポレイテッド | Ｐｏｒｐｈｙｒｏｍｏｎａｓ ｇｉｎｇｉｖａｌｉｓペプチドを含む免疫原性組成物および方法 |
| US6833262B1 (en) | 1999-04-21 | 2004-12-21 | University Of Georgia Research Foundation, Inc. | Polypeptide having amidolytic activity for a serpin |
| AUPQ065299A0 (en) | 1999-05-28 | 1999-06-24 | University Of Sydney, The | A method of prophylaxis and treatment and agents useful for same |
| AUPQ485999A0 (en) * | 1999-12-24 | 2000-02-03 | Csl Limited | P. gingivalis antigenic composition |
| US7378101B2 (en) | 2001-12-21 | 2008-05-27 | Pfizer, Inc. | Vaccine for periodontal disease |
| GB0411150D0 (en) | 2004-05-19 | 2004-06-23 | Queen Mary & Westfield College | Vaccine |
| MX2012001495A (es) | 2009-08-02 | 2012-08-03 | Sanofi Pasteur Ltd | Polipeptidos de porphyromonas gingivalis. |
| AU2011214908A1 (en) | 2010-02-12 | 2012-09-20 | Sydney West Area Health Services (Swahs) | Protein domains and uses therefor |
| WO2011130544A2 (en) | 2010-04-14 | 2011-10-20 | Sutro Biopharma, Inc. | Monitoring a dynamic system by liquid chromatography-mass spectrometry |
| WO2014058830A1 (en) | 2012-10-12 | 2014-04-17 | Sutro Biopharma, Inc. | Proteolytic inactivation of select proteins in bacterial extracts for improved expression |
| EP3365027B1 (en) * | 2015-10-14 | 2022-03-30 | Research Institute at Nationwide Children's Hospital | Hu specific antibodies and their use in inhibiting biofilm |
| CN111225684A (zh) | 2017-10-12 | 2020-06-02 | Sutrovax公司 | 牙周炎疫苗和相关组合物及使用方法 |
-
2018
- 2018-10-11 CN CN201880065401.1A patent/CN111225684A/zh active Pending
- 2018-10-11 MX MX2020003810A patent/MX2020003810A/es unknown
- 2018-10-11 CA CA3078630A patent/CA3078630A1/en active Pending
- 2018-10-11 EA EA202090908A patent/EA202090908A1/ru unknown
- 2018-10-11 KR KR1020207013299A patent/KR102530966B1/ko active Active
- 2018-10-11 MA MA050363A patent/MA50363A/fr unknown
- 2018-10-11 KR KR1020237015301A patent/KR20230066660A/ko not_active Ceased
- 2018-10-11 EP EP18797289.8A patent/EP3694547A1/en active Pending
- 2018-10-11 SG SG11202003147XA patent/SG11202003147XA/en unknown
- 2018-10-11 WO PCT/US2018/055496 patent/WO2019075260A1/en not_active Ceased
- 2018-10-11 JP JP2020520602A patent/JP7258870B2/ja active Active
- 2018-10-11 US US16/158,155 patent/US10835590B2/en active Active
- 2018-10-11 AU AU2018347511A patent/AU2018347511A1/en not_active Abandoned
-
2020
- 2020-03-29 IL IL273690A patent/IL273690A/en unknown
- 2020-04-08 PH PH12020550239A patent/PH12020550239A1/en unknown
-
2021
- 2021-05-05 US US17/308,872 patent/US11701414B2/en active Active
-
2023
- 2023-04-05 JP JP2023061241A patent/JP2023098935A/ja active Pending
- 2023-05-30 US US18/325,563 patent/US12121575B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US11701414B2 (en) | 2023-07-18 |
| CA3078630A1 (en) | 2019-04-18 |
| WO2019075260A1 (en) | 2019-04-18 |
| EA202090908A1 (ru) | 2020-10-29 |
| IL273690A (en) | 2020-05-31 |
| US20190192645A1 (en) | 2019-06-27 |
| JP2020536925A (ja) | 2020-12-17 |
| US20240131134A1 (en) | 2024-04-25 |
| PH12020550239A1 (en) | 2021-02-15 |
| US20210361756A1 (en) | 2021-11-25 |
| JP7258870B2 (ja) | 2023-04-17 |
| KR102530966B1 (ko) | 2023-05-15 |
| KR20230066660A (ko) | 2023-05-16 |
| AU2018347511A1 (en) | 2020-05-21 |
| EP3694547A1 (en) | 2020-08-19 |
| US10835590B2 (en) | 2020-11-17 |
| KR20200070302A (ko) | 2020-06-17 |
| AU2018347511A8 (en) | 2020-06-11 |
| CN111225684A (zh) | 2020-06-02 |
| BR112020006500A2 (pt) | 2020-10-13 |
| US20240226259A9 (en) | 2024-07-11 |
| SG11202003147XA (en) | 2020-05-28 |
| JP2023098935A (ja) | 2023-07-11 |
| US12121575B2 (en) | 2024-10-22 |
| MX2020003810A (es) | 2020-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3694390A4 (en) | ENDOSCOPE AND METHOD OF USE | |
| EP3630199A4 (en) | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS FOR THEIR USE | |
| EP3630788A4 (en) | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS FOR THEIR USE | |
| EP3630789A4 (en) | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS FOR THEIR USE | |
| EP3704239A4 (en) | CASZ COMPOSITIONS AND METHOD OF USE | |
| EP3352774A4 (en) | FLAVONOID COMPOSITIONS AND METHODS OF USE | |
| EP3749343A4 (en) | FORMULATION AND METHOD OF USE | |
| EP3313404A4 (en) | THERAPEUTIC COMPOSITIONS, COMBINATIONS AND METHODS OF USE | |
| EP3355954A4 (en) | RELEASE PROCEDURE AND COMPOSITIONS | |
| HUE055458T2 (hu) | Kompozíciók és módszerek 5'-Cap RNS-ek szintézisére | |
| MA46481A (fr) | Compositions d'oligonucléotides et méthodes associées | |
| EP3463440A4 (en) | NEOEPITOP VACCINE COMPOSITIONS AND METHOD FOR USE THEREOF | |
| EP3435956A4 (en) | PHOTO-STABILIZED COMPOSITIONS AND METHODS OF USE | |
| MA41999A (fr) | Compositions d'acide obéticholique et procédés d'utilisation | |
| EP3377615A4 (en) | HAPLOID INDUCTION COMPOSITIONS AND METHOD OF USE THEREOF | |
| EP3416665A4 (en) | FORMULATION AND METHOD FOR USE | |
| EP3341017A4 (en) | IMMUNOMODULATING COMPOSITIONS AND METHOD FOR USE THEREOF | |
| EP3319612A4 (en) | OXYSTEROLS AND METHOD OF USE THEREOF | |
| EP3319610A4 (en) | OXYSTEROLS AND METHOD OF USE THEREOF | |
| EP3830109A4 (en) | METHODS AND COMPOSITIONS FOR ALPHAVIRUS VACCINATION | |
| EP3490569A4 (en) | TOPICAL COMPOSITIONS AND METHODS FOR USE THEREOF | |
| EP3380525A4 (en) | PHARMACEUTICAL FORMULATIONS AND METHOD FOR USE THEREOF | |
| EP3347449A4 (en) | ZELLEX PANSION PROCEDURE AND THERAPEUTIC COMPOSITIONS | |
| PL3606929T3 (pl) | Nukleotydy estru beta-nikotynianowego i sposoby ich wytwarzania | |
| EP3364986A4 (en) | PLASMA COMPOSITIONS AND METHOD FOR USE THEREOF |